|
Terumo Interventional
Systems Expands World-Class Transradial Access Solutions Portfolio
With Introduction Of Heartrail™ III Coronary Guiding Catheter
Company Moves Closer To Becoming Premier Global Transradial Access
Products Provider with Its First Guiding Catheter
|
 |
 |
|
September 24, 2010
-- Somerset, New Jersey -- Terumo Interventional Systems, a strategic business
unit of Terumo Medical Corporation, and leading manufacturer
of guidewires, catheters, sheaths, and embolization products,
today announced the nationwide availability of the new Heartrail™ III
Coronary Guiding Catheter, the company’s first guiding catheter
specifically designed for right radial access to maximize Transradial
interventional procedures. |
The Heartrail III guiding catheter is designed for use in the left- or right-coronary
artery. Heartrail III guiding catheters offer both Ikari and TIG radial tip shapes
that provide five distinct benefits:
- A curve design that specifically addresses the backup support needed
in a guiding catheter that is missing from many catheters that are used from
the right radial access;
- Bigger Lumen Size (6 Fr., 1.80mm inner diameter) – Features
a larger lumen as well as lower device friction to accommodate bigger stents
and balloons
without having to change out catheters;
- Flexible Shaft Design – Superior trackability,
even in tortuous vessels;
- Superior Torque Control – Smooth handling for accurate
engagement of the artery; and
- High Radiopacity – Enhanced visibility allows accurate
tip positioning in coronary ostium.
The Heartrail Guiding catheter is also available in Europe and Asia.
“I am a firm believer in the benefits of the Transradial access approach, which
is why I worked with Terumo engineers to develop a Judkins-style catheter specifically
designed to maximize radial procedures,” said Yuji Ikari, MD, PhD, FACC, Professor,
Department of Cardiology, Tokai University School of Medicine, in Tokyo, Japan. “The
Heartrail III’s unique brachiocephalic curve provides a larger, more secure contact
point between the catheter and the reverse side of the aorta that leads to a
greater angle between the aorta and the catheter. This results in extremely strong
backup force to help brace device placement.”
Transradial access uses the arteries of the wrist, rather than the groin,
to gain access to the heart. It is the leading access strategy in many
countries of the world and while the technique accounts for an estimated
three to five percent of cases in the U.S., there is a growing interest
among physicians for more specialized tools that facilitate the procedure.
“The Heartrail guide catheters are Terumo’s initial attempt to bring physicians
specific tools that will help facilitate procedural outcomes when accessing the
coronaries from the right radial artery. Specifically, the Ikari catheters were
designed to be “Judkin’s-like” with great backup support, something that the
traditional femoral shape catheters don’t offer from the right radial access,” said
Gary Clifton, Senior Marketing Manager, Terumo Medical Corporation. “In addition
to providing educational information and transradial access training to physicians,
Terumo is committed to delivering a complete set of tools that will enhance successful
outcomes and quality of life for patients undergoing PCI procedures via the radial
access.” For more information about the new Heartrail III Coronary Guiding
Catheter, please call 800-862-4143 to speak to an Inside Sales Specialist
or visit www.terumois.com.
Terumo Interventional Systems
Terumo Interventional Systems (TIS), a strategic business unit of Terumo Medical
Corporation, directly markets a full line of guidewires, catheters, introducer
sheaths, guiding sheaths and embolization products for use in a multitude of
different interventional procedures.
Interventional Radiologists, Interventional Neuroradiologists, Interventional
Cardiologists, and Vascular Surgeons are among the medical professionals that
depend upon TIS products to access and cross difficult-to-reach lesions, thereby
allowing therapeutic intervention in previously unreachable vascular beds.
Terumo Medical Corporation
Founded in 1972 as a Terumo Corporation subsidiary, Terumo Medical Corporation (TMC) develops, manufactures, and markets high-quality medical devices used in a broad range of applications in numerous healthcare markets. TMC manufactures a broad portfolio of needles and syringes, entry-site management products, and a line of sterile connection devices used in hospitals and blood banks worldwide.
Terumo Corporation
Tokyo-based Terumo Corporation is one of the world’s leading medical
device manufacturers with $3.0 billion in sales and operations in more
than 160 nations. Founded in 1921, the company develops, manufactures,
and distributes world-class medical devices including products for use
in cardiothoracic surgery, interventional procedures, and transfusion
medicine; the company also manufactures a broad array of syringe and
hypodermic needle products for hospital and physician office use. Terumo
contributes to society by providing valued products and services to
the healthcare market and by responding to the needs of healthcare providers
and the people they serve.
Terumo Corporation’s shares are listed on the first section of the Tokyo Stock Exchange (No. 4543, Reuters symbol <4543.T>, or Bloomberg 4543: JP) and is a component of the Nikkei 225, Japan’s
leading stock index.
Source: Terumo Interventional Systems
|
